Dr. Meghana Ransing
CEO and Cofounder of p-matrix Ltd, co-inventor of patented diagnostic AI for manufacturing. Leads 7Epsilon adoption and penalty matrices training, driving quality improvement, digital manufacturing, and innovation across global industries.
About Dr. Meghana Ransing
Dr. Meghana Ransing, Ph.D., is CEO and Co-founder of p-matrix Ltd and co-inventor of patented diagnostic AI for manufacturing. She leads the adoption of 7Epsilon and penalty matrices training, driving digital transformation and quality improvement across industries.
With over 25 years of experience spanning academia, industry, and international collaborations, Meghana has delivered regulatory and risk-management innovations in medical devices, investment casting, and advanced manufacturing.
Her career highlights include:
- Smart Partnership (Swansea University & DTR Medical) – created AI-enabled FMEA tools aligned with AIAG-VDA, built regulatory software prototypes, and delivered international workshops, including to UNISA in South Africa.
- CEO, p-matrix Ltd – led design of data acquisition systems and applied advanced analytics to reduce scrap and improve manufacturing performance in UK-India foundries.
- Training and Adoption – co-pioneered international training programmes in 7Epsilon, equipping 180+ engineers in the UK, EU, US, and Asia with methods for data-driven root cause analysis.
- Invited Lectures – delivered talks at international conferences and forums, sharing insights on AI for diagnostics, risk management, and quality improvement in manufacturing.
- Project Leadership – delivered web-based quality improvement systems at Swansea University, co-founded MetaCause Solutions Ltd, and worked with governments, universities, and industries worldwide.
Meghana is passionate about applying AI, deep learning, and knowledge engineering to solve real-world manufacturing challenges, while building strong collaborations between industry, academia, and technology providers.
